Name
*
First Name
Last Name
Email
*
example@example.com
What best describes your title?
*
MD/DO
RN/NP
PA
PharmD
Industry
Other
If physician, please denote specialty:
Cardiologist
Nephrologist
Endocrinologist
Hospitalist
Other Internal Medicine Specialist
Neurologist
Primary Care
Other
How many years have you been in practice?
How many patients do you typically see each month?
1. Which of the following was NOT one of the findings of the study we considered in this Twitter Journal Club, "Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes"?
*
a. The primary outcome (the composite of an episode of worsening heart failure or cardiovascular death) was significantly less common in subjects with diabetes with dapaglifozin compared to placebo
b. The primary outcome (the composite of an episode of worsening heart failure or cardiovascular death) was significantly less common in subjects without diabetes with dapaglifozin compared to placebo
c. Composite kidney outcome was less common, though not significantly reduced, with dapaglifozin compared to placebo
d. The higher the baseline HbA1c, the smaller the benefit observed with dapaglifozin compared to placebo on the primary endpoint of CV death or worsening HF events
2. Did you follow the entire tweetorial?
*
Yes
No
3. Did you find this to be an effective learning tool?
*
Yes
No
4. Will you refer colleagues to similar programs from @cardiomet_ce?
*
Yes
No
-
Month
-
Day
Year
2 digit month, 2 digit day, 4 digit year
Date
Claim Certificate
Should be Empty: